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Objective: Type I attachment site endoleaks are the most common cause for reintervention after thoracic endovascular
aortic repair (TEVAR) and represent treatment failures. Deployment of endografts in segments of the aorta previously
replaced with Dacron grafts may be associated with reduced type I endoleak due to mechanical stability and decreased
potential for aortic remodeling. However, no study has rigorously examined endoleak rates in Dacron landing zones vs
native aorta.
Methods: A retrospective analysis of a prospectively maintained database was performed to identify all patients
undergoing TEVAR at a single referral institution between May 2002 and June 2012. Overall, 319 patients
undergoing 345 procedures had at least one follow-up contrast-enhanced computed tomography scan to assess for
postoperative type I endoleak. Attachment site landing zones were classiﬁed as native aorta, Dacron, or endograft if
landed in a previously placed endograft. Patient characteristics and type I endoleak rates were compared among the
three groups.
Results: Identiﬁed were 697 proximal or distal landing zones (native aorta, 599; Dacron, 79; and endograft, 19). Patients
with at least one Dacron landing zone had higher rates of hypertension (P < .01), chronic obstructive pulmonary disease
(P [ .04), and prior aortic surgery (P < .01) and were more likely to have undergone complex hybrid repairs (P < .01).
Cumulative type I endoleak rates were equivalent between the three types of landing zone (native aorta, 3.7%; Dacron,
2.5%; endograft, 0%; P [ .44). Two type I endoleaks occurred with Dacron landing zones in the ﬁrst tertile of TEVAR
experience and with Dacron landing zone lengths of <2.5 cm. Evaluation of endoleak rates by tertile of experience
demonstrated decreased type I endoleak rates in Dacron landing zones between the ﬁrst and second/third tertiles of
experience (13.3% vs 0%, P [ .03) after a policy of using >4 to 5 cm (twice the device instructions for use) of Dacron
overlap was initiated.
Conclusions: Endograft deployment within long-segment (landing zone length of >4-5 cm) Dacron represents a durable
option for aortic repair and was associated with a 0% rate of type I endoleak. In cases of a borderline native aortic landing
zone, a hybrid procedure to create an adequate Dacron landing zone may be warranted to decrease the risk of type I
endoleak and treatment failure. (J Vasc Surg 2014;59:921-9.)Thoracic endovascular aortic repair (TEVAR) allows
for less invasive aortic repair with reduced perioperative
morbidity compared with open surgery1,2 but remains
limited by the need for secondary reinterventions,
primarily due to endoleak. Type I attachment site endo-
leaks occurring at the proximal (Ia) or distal (Ib) landing
zone represent treatment failures and are the mostthe Divisions of Cardiovascular and Thoracic Surgerya and Vascular
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://dx.doi.org/10.1016/j.jvs.2013.10.086common cause of reintervention after TEVAR.3-5 Type
I endoleaks are observed after 2% to 15% of TEVAR
procedures, and 3% to 8% of TEVAR patients require
reintervention for type I endoleak.3,4,6-11 Established
risk factors for type I endoleak include age, repair of fusi-
form aneurysms, long-segment aortic coverage, male sex,
and large aneurysm size.12-15 Although these risk factors
cannot be modiﬁed, several authors have reported low
endoleak rates when endografts are deployed with seal
zones in previously replaced segments of Dacron
aorta.16-18 Placement of an endograft in a segment of
replaced Dacron aorta may allow for reduced endoleak
due to mechanical stability and decreased remodeling of
the landing zone.19 However, no study has directly exam-
ined the incidence of type I endoleak after endograft
deployment in Dacron compared with native aorta.
Consequently, the objective of the present study was to
compare the rate of type I endoleak occurring in Dacron
landing zones vs native aorta landing zones using a large,
single-institution TEVAR database that contains a high
proportion of complex hybrid reconstructions involving
endograft landing zones in segments of previously recon-
structed Dacron aorta.921
Fig 1. Example of Dacron landing zones used with thoracic endovascular aortic repair (TEVAR). A, Proximal landing
zone in Dacron elephant trunk and distal landing zone in thoracoabdominal aortic aneurysm (TAAA) repair Dacron
graft for total aortic replacement. B, Proximal and distal Dacron landing zones in the descending thoracic portion of
a Dacron TAAA graft for progressive enlargement of an intercostal patch aneurysm (arrow) developing late after prior
open extent II TAAA repair in a Marfan patient. This patient had also undergone prior visceral patch aneurysm repair
through a hybrid approach including visceral debranching and endograft exclusion of the pseudoaneurysm, and this
repair is partially visible at the bottom portion of the ﬁgure.
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This study was reviewed and approved by the Duke
University Institutional Review Board. The need for indi-
vidual patient consent was waived.
Patients and data source. A retrospective review was
performed of prospectively collected data from all patients
undergoing TEVAR at a single referral institution. Preop-
erative, intraoperative, and postoperative variables were
abstracted from the Duke Thoracic Aortic Surgery Data-
base, a prospectively maintained clinical registry of all
patients undergoing thoracic aortic surgery at Duke
University Medical Center (Durham, NC).
A query of the database identiﬁed 433 TEVAR proce-
dures performed between May 2002 and October 2012.
Of these, 345 procedures (80%) had at least one postoper-
ative computed tomography angiography (CTA) scan
during follow-up and constituted the study cohort, with
the remaining 88 procedures excluded secondary to lack
of follow-up imaging. Comorbidities and patient character-
istics were deﬁned using The Society of Thoracic Surgeons
deﬁnitions (www.sts.org). The proximal and distal landing
zones used in each procedure were individually classiﬁed as
native aorta, Dacron, or pre-existing endograft. Native
aorta landing zones consisted of any endograft landing
zone in native aorta. Dacron landing zones consisted of
any endograft proximal or distal landing zone in a Dacron
graft placed during a prior or concomitant procedure(Fig 1). Endograft landing zones consisted of any endog-
raft proximal or distal landing zone in an existing thoracic
or abdominal aortic endograft placed at a prior operation.
Each procedure was then classiﬁed as native aorta (the
procedure involved only native landing zones), Dacron
(the procedure involved at least one Dacron landing
zone), or endograft (the procedure involved an endograft
and native landing zones). Seven patients who underwent
hybrid thoracoabdominal aortic repair that used a bifur-
cated abdominal device with a distal seal in the iliac arteries
were counted as having two distal landing zones.20
Patient medical records and imaging studies were
reviewed to identify patients experiencing type I endo-
leak. Type II and III endoleaks were not included in
the analysis because these are not related to characteristics
of the endograft seal zone (ie, native aorta, Dacron, or
endograft). Type I endoleak rates were calculated by the
number of landing zones at risk for endoleak (n ¼ 697)
and not as a percentage of the procedures in which a post-
operative endoleak developed. The presence of a learning
curve was assessed by stratifying endoleak rates by tertile
of institutional TEVAR experience. Tertiles were classi-
ﬁed by the sequential order in which each procedure
was performed.
Conduct of procedures. All commercially available
thoracic endografts were used during the study period
and included the Gore TAG and C-TAG (W. L. Gore &
Table I. Patient and operative characteristics
Variablea
Landing zone
PNative (n ¼ 264) Dacron (n ¼ 66) Endograft (n ¼ 15)
Demographics
Age, years 63.6 6 14.8 63.7 6 12.2 61.3 6 14.5 .83
Male gender 157 (59.5) 37 (56.1) 10 (66.7) .73
White race 170 (64.4) 38 (57.6) 10 (66.7) .57
Body mass index, kg/m2 28.2 6 5.9 26.6 6 5.6 28.7 6 4.0 .13
Comorbidities
Hypertension 225 (85.2) 64 (97.0) 15 (100) <.01b
Hyperlipidemia 153 (58.0) 40 (60.6) 9 (60.0) .92
History of tobacco use 171 (64.8) 47 (71.2) 8 (53.3) .37
Diabetes 44 (16.7) 5 (7.6) 1 (6.7) .09
Coronary artery disease 76 (28.8) 20 (30.3) 3 (20.0) .71
History of stroke/TIA 24 (9.1) 12 (18.2) 1 (6.7) .12
COPD 75 (28.4) 24 (36.4) 1 (6.7) .04b
Baseline creatinine >1.5 mg/dL 58 (22.0) 24 (36.4) 3 (20.0) .06
Peripheral vascular disease 64 (24.2) 19 (28.8) 2 (13.3) .41
Prior aortic surgery 71 (26.9) 65 (98.5)c 15 (100) <.01b
Indication
Aneurysm 153 (58.0) 41 (62.1) 6 (40.0) <.01b
Dissection 90 (34.1) 25 (37.9) 9 (60.0)
Transection 21 (8.0) 0 (0) 0 (0)
Principal procedure
Descending repair 203 (76.9) 12 (18.2) 12 (80.0) <.01b
Hybrid arch repair 37 (14.1) 18 (27.3) 0 (0)
Hybrid TAAA repair 24 (9.1) 21 (31.8) 3 (20.0)
Stented elephant trunk 0 (0) 15 (22.7) 0 (0)
COPD, Chronic obstructive pulmonary disease; TAAA, thoracoabdominal aortic aneurysm; TIA, transient ischemic attack.
aContinuous data are expressed as mean 6 standard deviation and categorical data as number (%).
bStatistically signiﬁcant (P < .05).
cIn one patient, a Dacron landing zone was created during same procedure as an endograft was placed.
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Vascular, Santa Rosa, Calif), and the Zenith TX2 and
investigational Zenith TX2-LP (Cook Medical, Bloo-
mington, Ind) devices. Preoperative planning of endograft
procedures was performed using curved planar reformats
with centerline analysis on an Aquarius three-dimensional
workstation (TeraRecon Inc, San Mateo, Calif).
Patient selection for TEVAR and techniques for device
delivery and deployment have been previously published.3,4
No patient left the operating room with a known type I
endoleak. Endografts deployed in native aorta used
a minimum of 2 to 2.5 cm of proximal and distal seal
zone and with percentage oversizing in accordance with
device instructions for use (IFU).3,4,21 Endografts
deployed in Dacron landing zones were upsized one
further size from the IFU. In our most recent experience,
we have changed our practice to use a longer landing
zone length (preferably >4-5 cm or twice the IFU) for
Dacron landing zones due to the observation of endoleaks
with shorter landing zones and because endografts may not
appose to the wall of a less-compliant Dacron graft in the
same manner as native aortic wall.19,22
This report includes all data collected through the
patients’ most recent follow-up visit. Routine follow-up
included clinical assessment accompanied by CTA at 1, 6,
and 12 months and annually thereafter. In addition,3-month follow-up assessment and imaging were obtained
in patients with an endoleak identiﬁed at 1 month if the
decision for initial endoleak observation was made. All
follow-up was done at the Duke University Center for
Aortic Surgery.
Statistical methods. Continuous and categorical vari-
ables were compared between groups using an unpaired
t-test or c2 test, respectively. Freedom from endoleak was
estimated using the Kaplan-Meier method and compared
between groups using the log-rank test.
RESULTS
The study cohort consisted of 345 procedures per-
formed in 319 patients. Of the 345 procedures, 264
(77%) involved only native landing zones, 66 (19%)
involved one or more Dacron landing zone, and 15 (4%)
involved an endograft and native landing zone. An endog-
raft landing zone was also used in four of the 66 procedures
(6.1%) involving a Dacron landing zone. A comparison of
patient and operative characteristics between procedures
involving native, Dacron, and endograft landing zones is
reported in Table I. Differences were observed in the base-
line rates of hypertension and chronic obstructive pulmo-
nary disease, with Dacron landing zone patients having
more comorbidities. Procedures using Dacron landing
zones occurred almost uniformly in patients who had
Table II. Landing zone characteristics
Variablea
Landing zone
PNative (n ¼ 599) Dacron (n ¼ 79) Endograft (n ¼ 19)
Location
Proximal 285 (47.6) 47 (59.5) 13 (68.4) .02b
Distal 314 (52.4) 32 (40.5) 6 (31.6)
Etiology of artiﬁcial landing zones
Prior open AAA repair 16 (20.2)
Prior open DTA repair 8 (10.1)
Prior ascending 6 hemiarch repair 17 (21.5)
Prior stage I elephant trunk procedure 14 (17.7)
Prior open TAAA repair 12 (15.2)
Multiple prior aortic procedures 12 (15.2)
Prior TEVAR 16 (84.2)
Prior EVAR 1 (5.2)
Prior hybrid arch repair 1 (5.2)
Prior hybrid TAAA repair 1 (5.2)
Follow-up duration, months 34.7 6 25.3 25.3 6 21.8 30.1 6 24.3 <.01b
AAA, Abdominal aortic aneurysm; DTA, descending thoracic aorta; EVAR, endovascular abdominal aortic aneurysm repair; TAAA, thoracoabdominal aortic
aneurysm; TEVAR, thoracic endovascular aortic repair.
aContinuous data are expressed as mean 6 standard deviation and categorical data as number (%).
bStatistically signiﬁcant (P < .05).
Table III. Type I endoleak rates by landing zone type
Variable
Landing zone
P
Native Dacron Endograft
No. (%)
(n ¼ 599)
No. (%)
(n ¼ 79)
No. (%)
(n ¼ 19)
Proximal (Ia) 13/285 (4.6) 2/47 (4.3) 0/13 (0) .55
Distal (Ib) 9/314 (2.9) 0/32 (0) 0/6 (0) .35
Total 22/599 (3.7) 2/79 (2.5) 0/19 (0) .44
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a Dacron landing zone had not undergone a previous
aortic operation. This patient underwent concomitant
ascending aorta and hemiarch replacement to create a prox-
imal Dacron landing zone at the time of zone 0 hybrid arch
debranching for a ruptured saccular midtransverse arch
aneurysm with concomitant dilated ascending aorta.
The indication for procedure differed between groups,
with procedures involving a native or Dacron landing
zone more likely to be performed for an aneurysm, whereas
those using an endograft landing zone were most
commonly for the development of metachronous distal
pathology after prior TEVAR. Transection repairs all
involved native landing zones only. Descending thoracic
aortic repair comprised the principal procedure for the
native landing zone group (77%), whereas the cohort with
a Dacron landing zone included an increased proportion
of complex hybrid reconstructions (82%).
We identiﬁed 599 native landing zones, 79 Dacron
landing zones, and 19 endograft landing zones
(Table II), and their fates were individually assessed. Native
landing zones were equally distributed between proximal
and distal location, whereas there were more proximal
than distal Dacron and endograft landing zones. Notably,
the duration of follow-up between the groups was statisti-
cally different (P < .01), with the longest follow-up ob-
tained for the native aorta landing zones and the shortest
for the Dacron landing zones.
The overall rate of type I endoleak was 3.4% (24 of 697
landing zones) when each landing zone was counted indi-
vidually, but 7.0% (24 of 345 procedures) when calculated
as a proportion of procedures performed. The rates of type
I endoleak by procedure type were 7.5% (17 of 227) for
descending repair, 9.1% (5 of 55) for hybrid arch repair,4.2% (2 of 48) for hybrid TAAA repair, and 0% (0 of 15)
for stented elephant trunk.
The type I endoleak rate in native landing zones (3.7%)
was equivalent to the endoleak rate in Dacron (2.5%) and
endograft landing zones (0%; Table III). These rates
remained equivalent upon Kaplan-Meier analysis of freedom
from endoleak performed to account for the differential
follow-up between groups (Fig 2). A comparison of endo-
leak rates between the ﬁrst and second/third tertiles of expe-
rience (Table IV), however, demonstrated a reduction in the
type I endoleak rate for all landing zones with increasing
experience (Fig 3), with the improvement due mainly to
decreased proximal type Ia endoleak rate. When the various
landing zone types were examined individually, a signiﬁcant
reduction in type I endoleak rate was observed for the
Dacron landing zones from the ﬁrst to the second/third ter-
tiles due to a signiﬁcant reduction in the proximal type Ia
endoleak rate, with similar signiﬁcant reduction in the type
Ia endoleak rate and a trend toward an overall reduced
type I endoleak rate in the native landing zones.
Fig 2. Comparison of actuarial freedom from endoleak by Kaplan-Meier analysis is shown for Dacron landing zones
(solid line), endograft landing zones (dashed line), and native landing zones (dotted line). SE, Standard error.
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small number of endograft landing zones. In addition, no
type I endoleaks occurred in the Dacron group after the ﬁrst
tertile of experience. However, upon Kaplan-Meier analysis
of freedom from endoleak performed to account for the
differential follow-up period between earlier and later ter-
tiles, only the Dacron landing zones were associated with
a decreased endoleak rate between tertiles (Fig 4).
Characteristics of the 22 type I endoleaks that occurred
with native aorta landing zones are reported in Table V.
The median time to endoleak detection was 131 days,
and the most common cause of type I endoleak in native
aorta was late dilation of the landing zone with loss of
endograft seal. Sixteen patients (73%) required interven-
tion, and the most common intervention was proximal
endograft extension. The other six patients did not
undergo reintervention due to advanced age, comorbid-
ities, or patient or family refusal. Four of the six patients
who did not undergo reintervention died of comorbid
conditions #1 year of discovery of the endoleak. One
potentially aortic related-death occurred in a 92-year-old
patient who refused reintervention and suffered sudden
death in an assisted-living facility 18 months after type Iendoleak detection. One additional octogenarian who
underwent TEVAR for a complicated type B dissection
remains alive and with stable aortic dimensions more
than 2 years after endoleak detection.
The two type I endoleaks with Dacron landing zones
(Table VI) occurred after zone 0 hybrid arch repair during
the ﬁrst tertile of institutional experience and were repaired
by use of a proximal extension graft. Notably, both patients
had a relatively short landing zone in Dacron (2 and
2.5 cm).
DISCUSSION
Although theoretically attractive as a means to reduce
type I attachment site endoleak due to their mechanical
stability and decreased potential for late remodeling, no
study has directly examined the incidence of type I endo-
leak after endograft deployment in Dacron vs native aorta.
As such, the current study presents a comparison of type I
endoleak rates in all potential proximal and distal attach-
ment site landing zones after TEVAR, including native
aorta and Dacron, and because a small number of patients
had landing zones in previously placed thoracic or abdom-
inal endografts, these landing zones were examined as well.
Table IV. Type I endoleak rates by tertile of institutional
experience
Variable
1st tertile
(n ¼ 229)
2nd/3rd tertiles
(n ¼ 468)
PNo. (%) No. (%)
Native landing zone
Proximal (Ia) 8/98 (8.2%) 5/187 (2.7%) .04a
Distal (Ib) 3/99(3.0) 6/215 (2.8) .90
Total 11/197 (5.6) 11/402 (2.7) .09
Dacron landing zone
Proximal (Ia) 2/15 (13.3) 0/32 (0) .03a
Distal (Ib) 0/10 (0) 0/22 (0) 1
Total 2/25 (8.0) 0/54 (0) .03a
Endograft landing zone
Proximal (Ia) 0/5 (0) 0/8 (0) 1
Distal (Ib) 0/2 (0) 0/4 (0) 1
Total 0/7 (0) 0/12 (0) 1
All landing zones
Proximal (Ia) 10/118 (8.5) 5/227 (2.2) <.01a
Distal (Ib) 3/111 (2.7) 6/241 (2.5) .91
Total 13/229 (5.7) 11/468 (2.4) .03a
aStatistically signiﬁcant (P < .05).
Fig 3. Type I endoleak rate by tertile of institutional experience.
Note statistically signiﬁcant reduction in the overall type I endo-
leak rate with increasing experience, including a signiﬁcant
reduction in type I endoleak rate for the Dacron landing zones
over time.
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landing zone among the three groups, were similar. Impor-
tantly, there was a decrease in the rate of type I endoleak
with Dacron landing zones after the ﬁrst tertile of experi-
ence, including a 0% rate of type I endoleak with Dacron
landing zones after an institutional change in policy to
ensure >4 to 5 cm of Dacron overlap (twice the IFU)
was initiated.
Although not the primary focus of any of the published
reports, four prior studies have reported experience with
endografts in a landing zone of Dacron-replaced or
Dacron-reinforced aorta (strip of Dacron placed around
native aorta), and none reported evidence of type I endo-
leak in these landing zones.16-18,23 Two of these studies
recommended a minimum overlap length of 4 to 5 cm in
Dacron aorta; however, this recommendation appeared to
be based on surgeon preference rather than objective
data.18,23 Early in our experience, we used device IFU to
judge the length of attachment site landing zone to be
adequate (>2-2.5 cm), and this practice likely resulted in
the two endoleaks that were observed within Dacron
landing zones, because both cases occurred with overlap
lengths of <2.5 cm. Both patients had undergone zone
0 hybrid arch repair using relatively short ascending aortic
woven Dacron grafts as proximal landing zones.
As a result of this experience, we have now come to
appreciate that many of these patients after prior type A
dissection repair are not suitable candidates for a hybrid
zone 0 approach to treating metachronously developing
arch/descending pathology unless concomitant hemiarch
replacement with distal anastomosis at the level of the
innominate artery was performed at the index repair. The
longer-length Dacron graft, as used for hemiarch repair,
does generally serve as an excellent proximal landing
zone in our experience, and this fact should probably beconsidered when an acute type A dissection is repaired,
given that at least one-third of these patients will need an
additional intervention for late-developing downstream
pathology after surgery for this condition and that dilation
of the distal aorta will develop in more than half.24-28
Notably, to our knowledge, the two Dacron landing
zone endoleaks presented here represent the ﬁrst reported
endoleaks in a Dacron landing zone with TEVAR. Impor-
tantly, the Dacron landing zone type I endoleak rate fell to
0% in the second and third tertiles of experience when the
aforementioned policy of a minimum Dacron overlap
length of >4 to 5 cm was adopted, supporting the recom-
mendation of prior authors.18,20
Other factors may also explain the decrease in the
Dacron landing zone endoleak rate with time and experi-
ence. The devices used during the 10-year study period
have evolved, including improvements in device conform-
ability, and this may have potentially contributed to
decreased endoleaks as well, as we have postulated in prior
studies.4 In addition, certain tools were not used early in
the experience that most would now consider mandatory
for preoperative case planning, such as CTA reconstruction
using curved planar reformats with centerline analysis.
Finally, our institution constructed and began use of
a hybrid operating room with ﬁxed ﬂuoroscopic imaging
midway through the time of the study, and the vast
improvement in intraoperative imaging provided by use
of this hybrid operating room may have also played a role.
Another important point to consider is the relative clin-
ical disparity between patients who underwent endograft
placement in native or Dacron aorta. Patients who under-
went TEVAR with a Dacron landing zone had an increased
incidence of hypertension and chronic obstructive pulmo-
nary disease, with trends toward greater chronic renal
insufﬁciency and prior stroke/transient ischemic attack.
This increased incidence of select comorbidities indicates
Fig 4. Comparison of actuarial Kaplan-Meier freedom from endoleak is shown for tertile 1 (solid line) and tertiles 2 and
3 (dashed line) in the (A) native landing zone cohort, (B) in the cohort with a Dacron landing zone, and (C) across all
landing zones.
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tion represented a group at increased perioperative risk
because these comorbidities represent markers of greater
systemic disease burden and likely poorer-quality native
aorta, which would predispose to late endoleak in the
absence of hybrid repair.4
Also notable is that the distribution of procedures
involving TEVAR differed between the two groups.
Patients in the native landing zone group were more likely
to undergo descending aortic repair alone, whereas patients
in the Dacron landing zone group tended to undergo more
complex aortic reconstructions, particularly arch or thora-
coabdominal hybrid repairs (81.8% hybrid repairs forDacron vs 23.2% for the native aorta group, respectively).
The relative equivalence in endoleak rates between the
native and Dacron landing zone cohorts additionally
argues that a Dacron landing zone provides a reliable
landing zone for endograft placement, even in high-risk
patients undergoing complex aortic reconstructions.
Also warranting discussion is the time to endoleak
detection, commonly occurring #30 days, but with some
endoleaks identiﬁed many years after the index procedure.
The median time to type I endoleak detection was
4.4 months (131 days), with 38% (nine of 24) noted in
the ﬁrst 30 days. Although Foley et al6 and Makaroun
et al29 have published similar results, other groups have
Table V. Characteristics of native landing zone type I
endoleaks
Variable
Native landing zone type
I endoleak (n ¼ 22)
No. (%) or median (range)
Location
Proximal (Ia) 13 (59.1)
Distal (Ib) 9 (40.9)
Principal procedure
Descending repair 17 (77.3)
Hybrid arch repair 3 (13.6)
Hybrid TAAA repair 2 (9.1)
Stented elephant trunk 0 (0)
Time to detection, days 131 (5-1601)
Intervention required 16 (72.7)
Proximal extension 8 (36.3)
Distal extension 2 (9.1)
Hybrid arch repair 2 (9.1)
Hybrid TAAA repair 2 (9.1)
Stented elephant trunk 1 (4.5)
Left subclavian artery occlusion 1 (4.5)
None 6 (27.3)
TAAA, Thoracoabdominal aortic aneurysm.
Table VI. Characteristics of Dacron landing zone type I
endoleaks
Patient Location
Principal
procedure
Landing
zone
length, cm
Time to
detection,
days Intervention
1 Proximal
(Ia)
Hybrid
arch
2.0 37 Proximal
extension
2 Proximal
(Ia)
Hybrid
arch
2.5 115 Proximal
extension
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ﬁrst 30 days. In these latter studies, the proportion of
type I endoleaks detected #30 days ranged from 59% to
86%.7,12,14,30,31 Most of the endoleaks noted in the ﬁrst
30 days are likely the result of a missed endoleak present
at the time of the index operation, potentially secondary
to technical error, improper graft sizing due to inadequate
preoperative case planning as might occur without the use
of centerline CTA reconstruction, or inadequate intraoper-
ative imaging, such as when a portable C-arm rather than
ﬁxed imaging such as in a hybrid operating room, is
used. Late endoleaks (>6 months) are more likely the
result of aortic remodeling.
The theoretic beneﬁt of a Dacron landing zone is that
it is potentially less susceptible to aortic remodeling than
native aorta and therefore may be more resistant to delayed
endoleak. In the current study, no Dacron landing zone
endoleaks occurred >6 months, consistent with a potential
protection from delayed type I endoleak. Regardless, we
believe lifelong imaging follow-up of these patients remains
mandatory given the lack of robust long-term data to
suggest otherwise.Although not the primary focus of the study, we felt
that landing zones in previously placed aortic endografts
required special analysis as a unique landing zone group
distinct from Dacron landing zones. These landing zones
contain wire frames and are not equivalent to Dacron or
native aorta. In addition, we did not believe it would be
appropriate to classify endoleaks at these sites as interjunc-
tional type III endoleaks because the stent graft in which
the landing zone occurred had been in place for some
time, and any endoleak at this area would likely be more
representative of a type I attachment site endoleak. This
classiﬁcation is certainly debatable; however, importantly,
no endoleaks were noted using endograft landing zones,
although only 19 were used in the study.
This study has a number of important limitations,
including the retrospective, observational nature of the
study, and that postoperative follow-up imaging for endo-
leak analysis was performed in only 80% of patients.
Although seemingly low, this number is among the highest
in the literature for large single-center series and, for
example, compares favorably with the 72% follow-up re-
ported by Lee et al5 from the University of Florida in their
report of 400 consecutive TEVARs.
Second, the shorter duration of follow-up for the
Dacron landing zones may underestimate the type I endo-
leak rate compared with native aorta, although as noted, no
Dacron endoleaks were noted >6 months, supporting the
stability of these landing zones over time. Further, the rela-
tively small number of Dacron landing zones (although the
largest in the literature to date) compared with those in
native aorta makes comparisons among the groups some-
what limited. In addition, as highlighted above, the pres-
ence of landing zones in previously placed endografts
provides a group that is somewhat difﬁcult to classify
because they are not truly representative of native aorta
or Dacron landing zones. Finally, the results presented
are from operations performed by two cosurgeons that
are not necessarily generalizable to other practices.
CONCLUSIONS
Patients undergoing TEVAR are at risk for type I
endoleak, and the current study demonstrates that Dacron
landing zones represent a durable option for TEVAR. In
cases of a borderline acceptable native aorta landing
zone, a hybrid approach to create a durable Dacron landing
zone may be preferable to avoid late treatment failure. In
this scenario, we recommend that at least 4 to 5 cm of
landing zone length (twice the device IFU) in Dacron be
used to prevent type I endoleak.
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